UnitedHealth Group names Andrew Witty CEO

Sir Andrew Witty is the new CEO of UnitedHealth Group. He succeeds David Wichmann, who is retiring, the healthcare company said Feb. 4.

Advertisement

Mr. Witty will take on the role immediately, while Mr. Wichmann will continue in a transitional role through March 2021. 

Mr. Witty was named CEO of Optum in March 2018, adding the role of president of UnitedHealth in November 2019. He has previously served as a company director for UnitedHealth.

In 2020, Mr. Witty took a leave of absence from April to December to serve as a global envoy for the World Health Organization’s COVID-19 efforts. He also was an adviser for the U.K. government’s vaccine taskforce. 

Prior to his time at UnitedHealth, Mr. Witty was the CEO and director of pharmaceutical company GlaxoSmithKline from 2008-17. He was knighted in 2012 for services to the U.K. economy.

Additionally, UnitedHealth named Dirk McMahon its new president and COO. Mr. McMahon has served as CEO of UnitedHealthcare, the company’s health insurance business, since June 2019. 

More articles on payers:
Blue Shield of California to oversee state’s COVID-19 vaccine distribution
Cigna ends prior authorization for some CT exams
UnitedHealth must redo 67K claims, judge rules

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Executive Moves

  • Optum Rx has named Jon Bosland as its next chief financial officer. “The PBM space is at an inflection point…

  • Several women have recently stepped into new executive roles at hospitals and health systems — including through promotions, new appointments…

Advertisement

Comments are closed.